GC
AMAG

Globeflex Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Globeflex Capital’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-41,137
Closed -$625K – 471
2018
Q4 		$625K Buy
41,137
+11,200
+37% +$213K 0.15% 232
2018
Q3 		$599K Buy
29,937
+22,237
+289% +$506K 0.12% 271
2018
Q2 		$150K Buy
7,700
+1,200
+18% +$26.5K 0.03% 400
2018
Q1 		$131K Sell
6,500
-37
-0.6% -$626 0.03% 394
2017
Q4 		$87K Sell
6,537
-8,840
-57% -$133K 0.02% 362
2017
Q3 		$284K Buy
15,377
+6,537
+74% +$122K 0.08% 270
2017
Q2 		$163K Hold
8,840
– – 0.04% 325
2017
Q1 		$199K Hold
8,840
– – 0.05% 364
2016
Q4 		$308K Hold
8,840
– – 0.08% 316
2016
Q3 		$217K Hold
8,840
– – 0.05% 335
2016
Q2 		$211K Sell
8,840
-11
-0.1% -$252 0.06% 327
2016
Q1 		$207K Hold
8,851
– – 0.06% 317
2015
Q4 		$267K Buy
8,851
+5,424
+158% +$175K 0.07% 290
2015
Q3 		$136K Sell
3,427
-20,205
-85% -$1.25M 0.03% 392
2015
Q2 		$1.63M Sell
23,632
-14,836
-39% -$933K 0.3% 91
2015
Q1 		$2.1M Sell
38,468
-6,438
-14% -$307K 0.4% 67
2014
Q4 		$1.91M Buy
+44,906
New +$1.62M 0.37% 80
2014
Q3 		– Sell
-81
Closed -$1K – 688
2014
Q2 		$1K Sell
81
-19
-19% -$351 ﹤0.01% 551
2014
Q1 		$1K Hold
100
– – ﹤0.01% 569
2013
Q4 		$2K Buy
+100
New +$2.35K ﹤0.01% 472

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Globeflex Capital's AMAG Position: Q1 2019 in Review

Globeflex Capital sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 41,137 shares — an estimated $625K sold.

Globeflex Capital first reported a position in AMAG in Q4 2013 and held it in 20 quarters. The position peaked at $2.1M in Q1 2015. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

  • Globeflex Capital reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Globeflex Capital sold 41,137 AMAG Pharmaceuticals shares in Q1 2019, an estimated $625K.
  • Globeflex Capital first reported a position in AMAG Pharmaceuticals in Q4 2013 and held it in 20 quarters.
  • Globeflex Capital's AMAG Pharmaceuticals position peaked at $2.1M in Q1 2015.
  • 166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on Globeflex Capital's 13F filing for Q1 2019, filed 10 May 2019.